Related Experiment Video
Updated: Jun 3, 2025
09:43
Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development
Published on: August 10, 2015
16.0K
CRRT Is More Than Just Continuous Renal Replacement Therapy
Lóránd Erdélyi1, Domonkos Trásy2
1Faculty of Helath and Sport Science, Széchenyi István University, 9026 Győr, Hungary.
Pharmaceuticals (Basel, Switzerland)
|January 8, 2025
Summary
Renal replacement therapies (RRT) mimic kidney function, but their optimal use and impact on drug pharmacokinetics require further investigation. Understanding RRT mechanisms and patient factors is key to successful treatment.
Area of Science:
- Nephrology
- Critical Care Medicine
- Pharmacology
Background:
- Kidney physiology and pathology are well-established.
- Renal replacement therapies (RRT) were developed to substitute lost kidney function.
- Continuous renal replacement therapy (CRRT) is an extracorporeal therapy for acute renal failure.
Purpose of the Study:
- To review the factors influencing the success of RRT.
- To explore the expanding applications of CRRT beyond renal replacement.
- To address unanswered questions regarding CRRT initiation, indications, and drug pharmacokinetics.
Main Methods:
- Literature review focusing on RRT mechanisms and influencing factors.
- Analysis of patient condition and physicochemical drug properties.
- Examination of CRRT's expanding indications and pharmacokinetic effects.
Main Results:
- RRTs replicate kidney excretory function using diffusion and convection.
- CRRT offers benefits beyond renal function substitution.
- New questions arise regarding CRRT's optimal use and drug interactions.
Conclusions:
- Further understanding of RRT mechanisms, patient factors, and drug properties is crucial.
- Optimizing RRT success requires a comprehensive approach.
- Research is needed to answer critical questions about CRRT's expanding role.
Related Concept Videos
01:27Dialysis
261
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
261
01:06Renal Drug Clearance: Overview
114
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
114
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
381
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
381
01:17Factors Affecting Renal Clearance: Renal Impairment
53
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
53
01:28Renal Drug Excretion: Tubular Secretion
117
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
117
01:11Renal Failure: Dose Adjustments
62
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
62